Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation
Prostate cancer (PCa) is a malignant disorder of prostate gland being asymptomatic in early
stages and high metastatic potential in advanced stages. The chemotherapy and surgical …
stages and high metastatic potential in advanced stages. The chemotherapy and surgical …
Exploiting the DNA Damage Response for Prostate Cancer Therapy
Simple Summary Localized prostate cancer has a favorable prognosis and can be
effectively treated with radiotherapy, as well as therapies that target hormone production and …
effectively treated with radiotherapy, as well as therapies that target hormone production and …
FOXD1 is associated with poor outcome and maintains tumor-promoting enhancer–gene programs in basal-like breast cancer
K Kumegawa, L Yang, K Miyata, R Maruyama - Frontiers in Oncology, 2023 - frontiersin.org
Breast cancer biology varies markedly among patients. Basal-like breast cancer is one of the
most challenging subtypes to treat because it lacks effective therapeutic targets. Despite …
most challenging subtypes to treat because it lacks effective therapeutic targets. Despite …